Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00705133
Recruitment Status : Completed
First Posted : June 25, 2008
Last Update Posted : March 6, 2018
United Therapeutics
Information provided by (Responsible Party):
Rajan Saggar, University of California, Los Angeles